NOX1 to NOX2 switch deactivates AMPK and induces invasive phenotype in colon cancer cells through overexpression of MMP-7

Abstract

BackgroundAlthough matrix metalloproteinase (MMP)-7 expression is correlated with increased metastatic potential in human colon cancer cells, the underlying molecular mechanism of invasive phenotype remains unknown. In the current study, we investigated the regulatory effects of membrane NADPH oxidase (NOX) and AMP activated protein kinase (AMPK) on MMP-7 expression and invasive phenotype change in colon cancer cells.MethodsProduction of superoxide anion was measured by lucigenin chemiluminescence assay using whole cells and protein extracts (NADPH oxidase activity), and intracellular reactive oxygen species (ROS) by fluorescence microscopy using 2’,7’-dichlorofluorescein diacetate (DCF-DA). Quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting were used to measure mRNA and protein levels, respectively. siRNA transfection was used to assess involvement of genes in cancer invasion, which were identified by Matrigel transwell invasion assay. Luciferase reporter assay was performed to identify transcription factors linked to gene expression.ResultsUnder basal conditions, less invasive human colon cancer cells (HT29 and Caco-2) showed low MMP-7 expression but high NOX1 expression and AMPK phosphorylation. Treatment of HT29 and Caco-2 cells with 12-O-tetradecanoylphorbol-13-acetate (TPA) induced an invasive phenotype response along with corresponding increases in ROS production and NOX2 and MMP-7 expression as well as reduced AMPK phosphorylation, which resemble basal conditions of highly invasive human colon cancer cells (SW620 and HCT116). In addition, inverse regulation between AMPK phosphorylation and NOX2 and MMP-7 expression was observed in HT29 cells treated with different concentrations of exogenous hydrogen peroxide. TPA-induced invasive phenotype in HT29 cells was abolished by treatment with Vit. E, DPI, apocynin, and NOX2 siRNA but not NOX1 siRNA, indicating NOX2-derived ROS production induced an invasive phenotype. TPA-induced induction of MMP-7 expression was suppressed by AP-1, NF-κB, and MAPK (ERK, p38, and JNK) inhibitors, whereas TPA-induced expression of NOX2 and its regulators, p47phox and p67phox, was blocked by p38 and NF-κB inhibitors.ConclusionsMolecular switch from NOX1 to NOX2 in colon cancer cells induces ROS production and subsequently enhances MMP-7 expression by deactivating AMPK, which otherwise inhibits stimulus-induced autoregulation of ROS and NOX2 gene expression.Electronic supplementary materialThe online version of this article (doi:10.1186/s12943-015-0379-0) contains supplementary material, which is available to authorized users.

Tryptophan hydroxylase 1 and 5-HT7 receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling

“…Invasion assays were performed as described by Banskota et al, 2015 [32] with slight modification. Briefly, the inner and outer surfaces of Transwell inserts (BD Falcon, Franklin Lakes, USA) were coated with matrigel and collagen, respectively.…”

Paradoxical roles of dual oxidases in cancer biology

“…The first NOX isoform that was linked to cancer biology is NOX1, which was originally identified as Mox1 and found to be capable of inducing cellular transformation and tumor growth [64]. NOX1 is primarily expressed in the colon, and was found to be overexpressed in colon cancers[65, 66], and also in radiation induced skin cancer[67], breast cancer [68], and oral squamous cell carcinoma[69]. Additionally, a growing number of studies have focused on a role for NOX4 in cancer biology.…”

4‐Hydroxynonenal‐induced GPR109A (HCA2 receptor) activation elicits bipolar responses, Gαi‐mediated anti‐inflammatory effects and Gβγ‐mediated cell death

“…Transcript numbers for NOX1, NOX2 and NOX4 were determined based on previously described methods (Banskota et al ., ). Briefly, human NOX1, NOX2 and NOX4 cDNAs (Invitrogen, Carlsbad, CA, USA) were cloned into the pcDNA5/FRT/TO vector (Invitrogen).…”